Relating to the disclosure by health care practitioners and facilities of patient liability for payment for certain health care services.
Impact
The bill aims to address the issue of unexpected medical bills, particularly regarding 'balance billing', where patients might be charged for the difference between what their insurance pays and what the provider charges. By requiring clearer communication from healthcare providers about potential liabilities, the bill seeks to protect patients from incurring unforeseen expenses related to their care. This legislation will modify existing provisions under the Insurance Code and related health statutes to enhance patient protection and informed consent regarding medical costs.
Summary
House Bill 3102 focuses on enhancing the transparency surrounding healthcare costs for patients. It mandates that health care practitioners and facilities must disclose the costs associated with their services to patients before care is rendered, with specific guidelines outlining how and when this information must be provided. A key provision is that at least three business days prior to the provision of non-emergency services, providers must give a clear, written estimate of the services' price, thereby ensuring that patients are informed of their potential financial liability ahead of time.
Contention
One notable point of contention surrounding HB 3102 involves the implications for healthcare providers and insurance companies. Some stakeholders argue that the bill may impose additional administrative burdens on providers, who must comply with the new disclosure requirements. There are concerns about how these changes will affect patient care decisions and the operational dynamics within healthcare facilities. Additionally, debates have emerged regarding the adequacy and timing of disclosures, with some advocating for even more comprehensive measures to ensure patients fully understand their financial responsibilities before receiving care.
Relating to the regulation of controlled substances and the establishment of an electronic system for monitoring controlled substances; providing criminal penalties; authorizing a fee.
Relating to the regulation of controlled substances and the establishment of an electronic system for monitoring controlled substances; providing criminal penalties.
Relating to the pricing of certain health care goods and services and to the compensation of certain health insurance agents; providing an administrative penalty.